Pluto Bioinformatics

GSE76203: Integrative genomics identifies the molecular basis of resistance to Azacytidine therapy in Myelodysplastic Syndromes

Bulk RNA sequencing

RNA-seq of bone marrow CD34+ cells of myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) patients to identify at the molecular pathways involved in primary resistance to AZA therapy. SOURCE: Ashwin Unnikrishnan (ashwin.unnikrishnan@unsw.edu.au) - Stem Cell Lab University of New South Wales